Checkpoint Therapeutics Inc (CKPT)
3.735
+0.26
(+7.64%)
USD |
NASDAQ |
Nov 22, 16:00
3.72
-0.02
(-0.40%)
After-Hours: 20:00
Checkpoint Therapeutics Max Drawdown (5Y): 97.22% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 97.22% |
| September 30, 2024 | 97.22% |
| August 31, 2024 | 97.22% |
| July 31, 2024 | 97.22% |
| June 30, 2024 | 97.22% |
| May 31, 2024 | 97.22% |
| April 30, 2024 | 97.22% |
| March 31, 2024 | 97.22% |
| February 29, 2024 | 97.22% |
| January 31, 2024 | 97.22% |
| December 31, 2023 | 97.22% |
| November 30, 2023 | 97.22% |
| October 31, 2023 | 97.22% |
| September 30, 2023 | 97.22% |
| August 31, 2023 | 96.18% |
| July 31, 2023 | 95.96% |
| June 30, 2023 | 95.96% |
| May 31, 2023 | 95.96% |
| April 30, 2023 | 95.96% |
| March 31, 2023 | 95.50% |
| February 28, 2023 | 93.50% |
| January 31, 2023 | 93.50% |
| December 31, 2022 | 93.50% |
| November 30, 2022 | 92.60% |
| October 31, 2022 | 92.60% |
| Date | Value |
|---|---|
| September 30, 2022 | 92.60% |
| August 31, 2022 | 92.60% |
| July 31, 2022 | 92.60% |
| June 30, 2022 | 92.60% |
| May 31, 2022 | 92.60% |
| April 30, 2022 | 92.60% |
| March 31, 2022 | 92.60% |
| February 28, 2022 | 92.60% |
| January 31, 2022 | 92.60% |
| December 31, 2021 | 92.60% |
| November 30, 2021 | 92.60% |
| October 31, 2021 | 92.60% |
| September 30, 2021 | 92.60% |
| August 31, 2021 | 92.60% |
| July 31, 2021 | 92.60% |
| June 30, 2021 | 92.60% |
| May 31, 2021 | 92.60% |
| April 30, 2021 | 92.60% |
| March 31, 2021 | 92.60% |
| February 28, 2021 | 92.60% |
| January 31, 2021 | 92.60% |
| December 31, 2020 | 92.60% |
| November 30, 2020 | 92.60% |
| October 31, 2020 | 92.60% |
| September 30, 2020 | 92.60% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
91.33%
Minimum
Nov 2019
97.22%
Maximum
Sep 2023
94.01%
Average
92.60%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| Fortress Biotech Inc | 98.41% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -47.54 |
| Beta (5Y) | 1.229 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 81.17% |
| Historical Sharpe Ratio (5Y) | -0.3903 |
| Historical Sortino (5Y) | -0.7546 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.19% |